<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31936368</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>08</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Splicing Players Are Differently Expressed in Sporadic Amyotrophic Lateral Sclerosis Molecular Clusters and Brain Regions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">159</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9010159</ELocationID><Abstract><AbstractText>Splicing is a tightly orchestrated process by which the brain produces protein diversity over time and space. While this process specializes and diversifies neurons, its deregulation may be responsible for their selective degeneration. In amyotrophic lateral sclerosis (ALS), splicing defects have been investigated at the singular gene level without considering the higher-order level, involving the entire splicing machinery. In this study, we analyzed the complete spectrum (396) of genes encoding splicing factors in the motor cortex (41) and spinal cord (40) samples from control and sporadic ALS (SALS) patients. A substantial number of genes (184) displayed significant expression changes in tissue types or disease states, were implicated in distinct splicing complexes and showed different topological hierarchical roles based on protein-protein interactions. The deregulation of one of these splicing factors has a central topological role, i.e., the transcription factor YBX1, which might also have an impact on stress granule formation, a pathological marker associated with ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>La Cognata</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentile</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aronica</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Meibergdreef 9, 1105 Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavallaro</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072260">RNA Splicing Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072260" MajorTopicYN="N">RNA Splicing Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SALS molecular subtypes</Keyword><Keyword MajorTopicYN="N">YBX1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">hub-bottlenecks</Keyword><Keyword MajorTopicYN="N">motor cortex</Keyword><Keyword MajorTopicYN="N">non hub-bottlenecks</Keyword><Keyword MajorTopicYN="N">spinal cord</Keyword><Keyword MajorTopicYN="N">spliceosome</Keyword><Keyword MajorTopicYN="N">splicing factors</Keyword><Keyword MajorTopicYN="N">tissue-specific program</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31936368</ArticleId><ArticleId IdType="pmc">PMC7017305</ArticleId><ArticleId IdType="doi">10.3390/cells9010159</ArticleId><ArticleId IdType="pii">cells9010159</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Butti Z., Patten S.A. RNA Dysregulation in Amyotrophic Lateral Sclerosis. Front. Genet. 2018;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone B., La Cognata V., Sprovieri T., Ungaro C., Conforti F.L., And&#xf2; S., Cavallaro S. Alternative Splicing of ALS Genes: Misregulation and Potential Therapies. Cell. Mol. Neurobiol. 2019;40:1&#x2013;14. doi: 10.1007/s10571-019-00717-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-019-00717-0</ArticleId><ArticleId IdType="pubmed">31385134</ArticleId></ArticleIdList></Reference><Reference><Citation>Su C.-H., Tarn W.-Y. Alternative Splicing in Neurogenesis and Brain Development. Front. Mol. Biosci. 2018;5:12. doi: 10.3389/fmolb.2018.00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2018.00012</ArticleId><ArticleId IdType="pmc">PMC5816070</ArticleId><ArticleId IdType="pubmed">29484299</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj B., Blencowe B.J. Alternative Splicing in the Mammalian Nervous System: Recent Insights into Mechanisms and Functional Roles. Neuron. 2015;87:14&#x2013;27. doi: 10.1016/j.neuron.2015.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.05.004</ArticleId><ArticleId IdType="pubmed">26139367</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyn-Vanhentenryck S.M., Feng H., Ustianenko D., Duffi&#xe9; R., Yan Q., Jacko M., Martinez J.C., Goodwin M., Zhang X., Hengst U., et al. Precise temporal regulation of alternative splicing during neural development. Nat. Commun. 2018;9:2189. doi: 10.1038/s41467-018-04559-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04559-0</ArticleId><ArticleId IdType="pmc">PMC5989265</ArticleId><ArticleId IdType="pubmed">29875359</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter R.S., Jaamour F., Iwase S. Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders. Mol. Cell. Neurosci. 2018;87:35&#x2013;45. doi: 10.1016/j.mcn.2017.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2017.10.006</ArticleId><ArticleId IdType="pmc">PMC5828955</ArticleId><ArticleId IdType="pubmed">29254826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoskins A.A., Moore M.J. The spliceosome: A flexible, reversible macromolecular machine. Trends Biochem. Sci. 2012;37:179&#x2013;188. doi: 10.1016/j.tibs.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2012.02.009</ArticleId><ArticleId IdType="pmc">PMC3508674</ArticleId><ArticleId IdType="pubmed">22480731</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvinge H. Regulation of alternative mRNA splicing: Old players and new perspectives. FEBS Lett. 2018;592:2987&#x2013;3006. doi: 10.1002/1873-3468.13119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13119</ArticleId><ArticleId IdType="pubmed">29856907</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutzi D., Akinyi M.V., Mechtersheimer J., Frilander M.J., Ruepp M.-D. The emerging role of minor intron splicing in neurological disorders. Cell Stress. 2018;2:40&#x2013;54. doi: 10.15698/cst2018.03.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/cst2018.03.126</ArticleId><ArticleId IdType="pmc">PMC6558932</ArticleId><ArticleId IdType="pubmed">31225466</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma B., Akinyi M.V., Norppa A.J., Frilander M.J. Minor spliceosome and disease. Semin. Cell Dev. Boil. 2018;79:103&#x2013;112. doi: 10.1016/j.semcdb.2017.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2017.09.036</ArticleId><ArticleId IdType="pubmed">28965864</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cognata V., Iemmolo R., D&#x2019;Agata V., Scuderi S., Drago F., Zappia M., Cavallaro S. Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene. Curr. Genom. 2014;15:203&#x2013;216. doi: 10.2174/1389202915666140426003342.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389202915666140426003342</ArticleId><ArticleId IdType="pmc">PMC4064560</ArticleId><ArticleId IdType="pubmed">24955028</ArticleId></ArticleIdList></Reference><Reference><Citation>Turunen J.J., Niemel&#xe4; E.H., Verma B., Frilander M.J. The significant other: Splicing by the minor spliceosome. Wiley Interdiscip. Rev. RNA. 2013;4:61&#x2013;76. doi: 10.1002/wrna.1141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1141</ArticleId><ArticleId IdType="pmc">PMC3584512</ArticleId><ArticleId IdType="pubmed">23074130</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S.B., Bellini M. The assembly of a spliceosomal small nuclear ribonucleoprotein particle. Nucleic Acids Res. 2008;36:6482&#x2013;6493. doi: 10.1093/nar/gkn658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn658</ArticleId><ArticleId IdType="pmc">PMC2582628</ArticleId><ArticleId IdType="pubmed">18854356</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cognata V., D&#x2019;Agata V., Cavalcanti F., Cavallaro S. Splicing: Is there an alternative contribution to Parkinson&#x2019;s disease? Neurogenetics. 2015;16:245&#x2013;263. doi: 10.1007/s10048-015-0449-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-015-0449-x</ArticleId><ArticleId IdType="pmc">PMC4573652</ArticleId><ArticleId IdType="pubmed">25980689</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvinge H., Kim E., Abdel-Wahab O., Bradley R.K. RNA splicing factors as oncoproteins and tumour suppressors. Nat. Rev. Cancer. 2016;16:413&#x2013;430. doi: 10.1038/nrc.2016.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc.2016.51</ArticleId><ArticleId IdType="pmc">PMC5094465</ArticleId><ArticleId IdType="pubmed">27282250</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Fu X.-D. Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma. 2013;122:191&#x2013;207. doi: 10.1007/s00412-013-0407-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00412-013-0407-z</ArticleId><ArticleId IdType="pmc">PMC3660409</ArticleId><ArticleId IdType="pubmed">23525660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Rio D.C. Mechanisms and Regulation of Alternative Pre-mRNA Splicing. Annu. Rev. Biochem. 2015;84:291&#x2013;323. doi: 10.1146/annurev-biochem-060614-034316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060614-034316</ArticleId><ArticleId IdType="pmc">PMC4526142</ArticleId><ArticleId IdType="pubmed">25784052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ule J., Blencowe B.J. Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution. Mol. Cell. 2019;76:329&#x2013;345. doi: 10.1016/j.molcel.2019.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.09.017</ArticleId><ArticleId IdType="pubmed">31626751</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Liu J., Huang B.O., Xu Y.M., Li J., Huang L.F., Lin J., Zhang J., Min Q.H., Yang W.M., et al. Mechanism of alternative splicing and its regulation. Biomed. Rep. 2015;3:152&#x2013;158. doi: 10.3892/br.2014.407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2014.407</ArticleId><ArticleId IdType="pmc">PMC4360811</ArticleId><ArticleId IdType="pubmed">25798239</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E., Baas F., Iyer A., Asbroek A.L.T., Morello G., Cavallaro S. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol. Dis. 2015;74:359&#x2013;376. doi: 10.1016/j.nbd.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.002</ArticleId><ArticleId IdType="pubmed">25500340</ArticleId></ArticleIdList></Reference><Reference><Citation>Giulietti M., Piva F., D&#x2019;Antonio M., D&#x2019;Onorio De Meo P., Paoletti D., Castrignano T., D&#x2019;Erchia A.M., Picardi E., Zambelli F., Principato G., et al. SpliceAid-F: A database of human splicing factors and their RNA-binding sites. Nucleic. Acids Res. 2013;41:D125&#x2013;D131. doi: 10.1093/nar/gks997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks997</ArticleId><ArticleId IdType="pmc">PMC3531144</ArticleId><ArticleId IdType="pubmed">23118479</ArticleId></ArticleIdList></Reference><Reference><Citation>Heberle H., Meirelles G.V., Da Silva F.R., Telles G.P., Minghim R. InteractiVenn: A web-based tool for the analysis of sets through Venn diagrams. BMC Bioinform. 2015;16:169. doi: 10.1186/s12859-015-0611-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-015-0611-3</ArticleId><ArticleId IdType="pmc">PMC4455604</ArticleId><ArticleId IdType="pubmed">25994840</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou G., Soufan O., Ewald J., Hancock R.E.W., Basu N., Xia J. NetworkAnalyst 3.0: A visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47:W234&#x2013;W241. doi: 10.1093/nar/gkz240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz240</ArticleId><ArticleId IdType="pmc">PMC6602507</ArticleId><ArticleId IdType="pubmed">30931480</ArticleId></ArticleIdList></Reference><Reference><Citation>Basha O., Shpringer R., Argov C.M., Yeger-Lotem E. The DifferentialNet database of differential protein-protein interactions in human tissues. Nucleic Acids Res. 2018;46:D522&#x2013;D526. doi: 10.1093/nar/gkx981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx981</ArticleId><ArticleId IdType="pmc">PMC5753382</ArticleId><ArticleId IdType="pubmed">29069447</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakshit H., Rathi N., Roy D. Construction and Analysis of the Protein-Protein Interaction Networks Based on Gene Expression Profiles of Parkinson&#x2019;s Disease. PLoS ONE. 2014;9:e103047. doi: 10.1371/journal.pone.0103047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0103047</ArticleId><ArticleId IdType="pmc">PMC4149362</ArticleId><ArticleId IdType="pubmed">25170921</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Spampinato A.G., Cavallaro S. Molecular Taxonomy of Sporadic Amyotrophic Lateral Sclerosis Using Disease-Associated Genes. Front. Neurol. 2017;8:3. doi: 10.3389/fneur.2017.00152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00152</ArticleId><ArticleId IdType="pmc">PMC5395696</ArticleId><ArticleId IdType="pubmed">28469596</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam O.H., Rozhkov N.V., Shaw R., Kim D., Hubbard I., Fennessey S., Propp N., Fagegaltier D., Ostrow L., Phatnani H., et al. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep. 2019;29:1164&#x2013;1177.e5. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Guarnaccia M., Spampinato A.G., Salomone S., D&#x2019;Agata V., Conforti F.L., Aronica E., Cavallaro S. Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS. Sci. Rep. 2019;9:9968. doi: 10.1038/s41598-019-46355-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46355-w</ArticleId><ArticleId IdType="pmc">PMC6620285</ArticleId><ArticleId IdType="pubmed">31292500</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T., Chen S., Yu Y., Yan B., Haertlein T.C., Carrasco M.A., Tapia J.C., Zhai B., Das R., Lalancette-Hebert M., et al. FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 2012;2:799&#x2013;806. doi: 10.1016/j.celrep.2012.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.08.025</ArticleId><ArticleId IdType="pmc">PMC3483417</ArticleId><ArticleId IdType="pubmed">23022481</ArticleId></ArticleIdList></Reference><Reference><Citation>Groen E.J., Fumoto K., Blokhuis A.M., Engelen-Lee J., Zhou Y., Heuvel D.M.V.D., Koppers M., Van Diggelen F., Van Heest J., Demmers J.A., et al. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum. Mol. Genet. 2013;22:3690&#x2013;3704. doi: 10.1093/hmg/ddt222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt222</ArticleId><ArticleId IdType="pubmed">23681068</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M., Rouleau G.A., Dion P.A., Parker J.A. FET proteins regulate lifespan and neuronal integrity. Sci. Rep. 2016;6:25159. doi: 10.1038/srep25159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25159</ArticleId><ArticleId IdType="pmc">PMC4846834</ArticleId><ArticleId IdType="pubmed">27117089</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi B., O&#x2019;Connell J.D., Yamazaki T., Gangopadhyay J., Gygi S.P., Reed R. Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins. Sci. Rep. 2018;8:8755. doi: 10.1038/s41598-018-27136-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-27136-3</ArticleId><ArticleId IdType="pmc">PMC5993797</ArticleId><ArticleId IdType="pubmed">29884807</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Ling S.-C., Qiu J., Albuquerque C.P., Zhou Y., Tokunaga S., Li H., Qiu H., Bui A., Yeo G.W., et al. ALS-causative mutations in FUS/TLS confer gain- and loss-of-function by altered association with SMN and U1-snRNP. Nat. Commun. 2015;6:6171. doi: 10.1038/ncomms7171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7171</ArticleId><ArticleId IdType="pmc">PMC4338613</ArticleId><ArticleId IdType="pubmed">25625564</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Chi B., Xia W., Gangopadhyay J., Yamazaki T., Winkelbauer-Hurt M.E., Yin S., Eliasse Y., Adams E., Shaw C.E., et al. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish. Nucleic Acids Res. 2015;43:3208&#x2013;3218. doi: 10.1093/nar/gkv157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv157</ArticleId><ArticleId IdType="pmc">PMC4381066</ArticleId><ArticleId IdType="pubmed">25735748</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S., Lopez-Gonzalez R., Kunz R.C., Gangopadhyay J., Borufka C., Gygi S.P., Gao F.-B., Reed R. Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients. Cell Rep. 2017;19:2244&#x2013;2256. doi: 10.1016/j.celrep.2017.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.056</ArticleId><ArticleId IdType="pmc">PMC5653973</ArticleId><ArticleId IdType="pubmed">28614712</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Chitta R.K., High A.A., Taylor J.P. Global Analysis of TDP-43 Interacting Proteins Reveals Strong Association with RNA Splicing and Translation Machinery. J. Proteome Res. 2010;9:1104&#x2013;1120. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons M., Miguel L., Miel C., Avequin T., Juge F., Frebourg T., Campion D., Lecourtois M. Splicing factors act as genetic modulators of TDP-43 production in a new autoregulatory TDP-43 Drosophila model. Hum. Mol. Genet. 2017;26:3396&#x2013;3408. doi: 10.1093/hmg/ddx229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx229</ArticleId><ArticleId IdType="pubmed">28854702</ArticleId></ArticleIdList></Reference><Reference><Citation>Rode S., Ohm H., Zipfel J., Rumpf S. The spliceosome-associated protein Mfap1 binds to VCP in Drosophila. PLoS ONE. 2017;12:e0183733. doi: 10.1371/journal.pone.0183733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0183733</ArticleId><ArticleId IdType="pmc">PMC5570293</ArticleId><ArticleId IdType="pubmed">28837687</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Raphael A.R., LaDow E.S., McGurk L., Weber R.A., Trojanowski J.Q., Lee V.M., Finkbeiner S., Gitler A.D., Bonini N.M. Therapeutic modulation of eIF2alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 2014;46:152&#x2013;160. doi: 10.1038/ng.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Cao M., Zheng H., Tan X., Li L., Cui G., Xu J., Cao J., Ke K., Wu Q. Upregulation of SYF2 is associated with neuronal apoptosis caused by reactive astrogliosis to neuroinflammation. J. Neurosci. Res. 2014;92:318&#x2013;328. doi: 10.1002/jnr.23312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23312</ArticleId><ArticleId IdType="pubmed">24301298</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehadeh L.A., Yu K., Wang L., Guevara A., Singer C., Vance J., Papapetropoulos S. SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson&#x2019;s Disease. PLoS ONE. 2010;5:e9104. doi: 10.1371/journal.pone.0009104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009104</ArticleId><ArticleId IdType="pmc">PMC2817002</ArticleId><ArticleId IdType="pubmed">20161708</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.H.D., Galej W.P., Bai X.-C., Savva C.G., Newman A.J., Scheres S.H.W., Nagai K. The architecture of the spliceosomal U4/U6.U5 tri-snRNP. Nature. 2015;523:47&#x2013;52. doi: 10.1038/nature14548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14548</ArticleId><ArticleId IdType="pmc">PMC4536768</ArticleId><ArticleId IdType="pubmed">26106855</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahara M., Kitamura A., Kinjo M. U6 snRNA expression prevents toxicity in TDP-43-knockdown cells. PLoS ONE. 2017;12:e0187813. doi: 10.1371/journal.pone.0187813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0187813</ArticleId><ArticleId IdType="pmc">PMC5681290</ArticleId><ArticleId IdType="pubmed">29125873</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Diaz Z., Fang X., Hart M.P., Chesi A., Shorter J., Gitler A.D. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Boil. 2011;9:e1000614. doi: 10.1371/journal.pbio.1000614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R., Allen S.P., Goodall E.F., Kramer S., Ponger L.-L., Heath P.R., Milo M., Hollinger H.C., Walsh T., Highley J.R., et al. Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathol. Appl. Neurobiol. 2015;41:201&#x2013;226. doi: 10.1111/nan.12147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12147</ArticleId><ArticleId IdType="pmc">PMC4329387</ArticleId><ArticleId IdType="pubmed">24750211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.-C., Liang T.Y., Mazur C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L.-H., Fan X.-Y., Guo H., Wei W., Chen M.-M., Yan S.-F. Network strategy to investigate differential pathways in sporadic amyotrophic lateral sclerosis. J. Cancer Res. Ther. 2018;14:1057. doi: 10.4103/0973-1482.199453.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0973-1482.199453</ArticleId><ArticleId IdType="pubmed">30539846</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida A., Takahashi A., Kubo M., Saito S., Hosono N., Ohnishi Y., Kiyotani K., Mushiroda T., Nakajima M., Ozaki K., et al. A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. Hum. Mol. Genet. 2011;20:3684&#x2013;3692. doi: 10.1093/hmg/ddr268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr268</ArticleId><ArticleId IdType="pubmed">21665992</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber S., Stettler J., Filosa G., Colombo M., Jutzi D., Lenzken S.C., Schweingruber C., Bruggmann R., Bachi A., Barabino S.M., et al. Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants. EMBO J. 2016;35:1504&#x2013;1521. doi: 10.15252/embj.201593791.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593791</ArticleId><ArticleId IdType="pmc">PMC4946139</ArticleId><ArticleId IdType="pubmed">27252488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara T., Ariizumi Y., Shiga A., Kato T., Tan C.-F., Sato T., Miki Y., Yokoo M., Fujino T., Koyama A., et al. Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:4136&#x2013;4147. doi: 10.1093/hmg/ddt262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt262</ArticleId><ArticleId IdType="pubmed">23740936</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata T., Tokunaga E., Hattori S., Watari K., Murakami Y., Yamashita N., Oki E., Itou J., Toi M., Maehara Y., et al. Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer. Oncotarget. 2018;9:37216&#x2013;37228. doi: 10.18632/oncotarget.26469.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.26469</ArticleId><ArticleId IdType="pmc">PMC6324687</ArticleId><ArticleId IdType="pubmed">30647855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwano M., Shibata T., Watari K., Ono M. Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer. Cancer Sci. 2019;110:1536&#x2013;1543. doi: 10.1111/cas.14006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.14006</ArticleId><ArticleId IdType="pmc">PMC6500994</ArticleId><ArticleId IdType="pubmed">30903644</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Benitez J.A., Hoogstraaten R., Kee N., Hedlund E. Axon-seq decodes the motor axon transcriptome and its modulation in response to ALS. Stem Cell Rep. 2018;11:321596. doi: 10.1016/j.stemcr.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.11.005</ArticleId><ArticleId IdType="pmc">PMC6294264</ArticleId><ArticleId IdType="pubmed">30540963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasrin F., Rahman M.A., Masuda A., Ohe K., Takeda J.-I., Ohno K. HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wnt-insensitive MuSK isoform. Sci. Rep. 2014;4:6841. doi: 10.1038/srep06841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep06841</ArticleId><ArticleId IdType="pmc">PMC4213890</ArticleId><ArticleId IdType="pubmed">25354590</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Hir H., Sauli&#xe8;re J., Wang Z. The exon junction complex as a node of post-transcriptional networks. Nat. Rev. Mol. Cell Biol. 2016;17:41&#x2013;54. doi: 10.1038/nrm.2015.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2015.7</ArticleId><ArticleId IdType="pubmed">26670016</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson K.L., Dayton R.D., Orchard E.A., Ju S., Ringe D., Petsko G.A., Maquat L.E., Klein R.L. Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis. Gene. Ther. 2015;22:20&#x2013;28. doi: 10.1038/gt.2014.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gt.2014.101</ArticleId><ArticleId IdType="pmc">PMC4924570</ArticleId><ArticleId IdType="pubmed">25354681</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Ju S., Arjun A., Batarse A., Archbold H.C., Peisach D., Li X., Zhang Y., Tank E.M.H., Qiu H., et al. Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1. Proc. Natl. Acad. Sci. USA. 2015;112:7821&#x2013;7826. doi: 10.1073/pnas.1509744112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1509744112</ArticleId><ArticleId IdType="pmc">PMC4485101</ArticleId><ArticleId IdType="pubmed">26056265</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M., Chen J., Kuang L., Jin H., Kasarskis E.J., Zhu H. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc. Natl. Acad. Sci. USA. 2018;115:E11904&#x2013;E11913. doi: 10.1073/pnas.1810413115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810413115</ArticleId><ArticleId IdType="pmc">PMC6304956</ArticleId><ArticleId IdType="pubmed">30455313</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Bao P., Jiang X., Wang H., Qin M., Wang R., Wang T., Yang Y., Lorenzini I., Liao L., et al. Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity. Brain. 2019;142:1349&#x2013;1364. doi: 10.1093/brain/awz070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz070</ArticleId><ArticleId IdType="pmc">PMC6487333</ArticleId><ArticleId IdType="pubmed">30938419</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Eshov A., Guo J.U. C9orf72 Dipeptide Repeats Inhibit UPF1-Mediated RNA Decay Independent of Stress Granule Formation. BioRxiv. 2019:623769. doi: 10.1101/623769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/623769</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautbergue G.M., Castelli L.M., Ferraiuolo L., Sanchez-Martinez A., Cooper-Knock J., Higginbottom A., Lin Y.-H., Bauer C.S., Dodd J.E., Myszczynska M.A., et al. SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits. Nat. Commun. 2017;8:16063. doi: 10.1038/ncomms16063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16063</ArticleId><ArticleId IdType="pmc">PMC5504286</ArticleId><ArticleId IdType="pubmed">28677678</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihevc S.P., Baralle M., Buratti E., Rogelj B. TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins. Sci. Rep. 2016;6:33996. doi: 10.1038/srep33996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33996</ArticleId><ArticleId IdType="pmc">PMC5036055</ArticleId><ArticleId IdType="pubmed">27665936</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkar N., Kovalik T., Lorenzini I., Spangler S., Lacoste A., Sponaugle K., Ferrante P., Argentinis E., Sattler R., Bowser R. Artificial intelligence in neurodegenerative disease research: Use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:227&#x2013;247. doi: 10.1007/s00401-017-1785-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1785-8</ArticleId><ArticleId IdType="pmc">PMC5773659</ArticleId><ArticleId IdType="pubmed">29134320</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Shibagaki Y., Hattori S., Matsuoka M. Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs. Hum. Mol. Genet. 2015;24:1513&#x2013;1527. doi: 10.1093/hmg/ddu563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu563</ArticleId><ArticleId IdType="pubmed">25378556</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo F., Nizzardo M., Vashisht S., Molteni E., Melzi V., Taiana M., Salani S., Santonicola P., Di Schiavi E., Bucchia M., et al. Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons. Brain. 2019;142:276&#x2013;294. doi: 10.1093/brain/awy330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy330</ArticleId><ArticleId IdType="pmc">PMC6351774</ArticleId><ArticleId IdType="pubmed">30649277</ArticleId></ArticleIdList></Reference><Reference><Citation>Das R., Dufu K., Romney B., Feldt M., Elenko M., Reed R. Functional coupling of RNAP II transcription to spliceosome assembly. Genome Res. 2006;20:1100&#x2013;1109. doi: 10.1101/gad.1397406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1397406</ArticleId><ArticleId IdType="pmc">PMC1472470</ArticleId><ArticleId IdType="pubmed">16651655</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Reed R. FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP. Proc. Natl. Acad. Sci. USA. 2015;112:8608&#x2013;8613. doi: 10.1073/pnas.1506282112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1506282112</ArticleId><ArticleId IdType="pmc">PMC4507187</ArticleId><ArticleId IdType="pubmed">26124092</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.C., Ebmeier C.C., Podell E.R., Heimiller J., Taatjes D.J., Cech T.R. FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev. 2012;26:2690&#x2013;2695. doi: 10.1101/gad.204602.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.204602.112</ArticleId><ArticleId IdType="pmc">PMC3533074</ArticleId><ArticleId IdType="pubmed">23249733</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao R.Y., Ni Z., Pu S., Zhong G., Schmitges F.W., Braunschweig U., Blencowe B.J., Greenblatt J.F., Zhao Y. Regulation of transcription termination by FUS and TDP-43. BioRXiv. 2019:788778. doi: 10.1101/788778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/788778</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehringer A., Garcia-Mansfield K., Singh G., Bakkar N., Pirrotte P., Bowser R. ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export. Sci. Rep. 2017;7:14529. doi: 10.1038/s41598-017-14924-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14924-6</ArticleId><ArticleId IdType="pmc">PMC5674072</ArticleId><ArticleId IdType="pubmed">29109432</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanarat S., Str&#xe4;&#xdf;er K. Splicing and beyond: The many faces of the Prp19 complex. Biochim. Biophys. Acta (BBA) 2013;1833:2126&#x2013;2134. doi: 10.1016/j.bbamcr.2013.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2013.05.023</ArticleId><ArticleId IdType="pubmed">23742842</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmar B., Greensmith L. Cellular Chaperones As Therapeutic Targets in ALS to Restore Protein Homeostasis and Improve Cellular Function. Front. Mol. Neuro Sci. 2017;10:251. doi: 10.3389/fnmol.2017.00251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00251</ArticleId><ArticleId IdType="pmc">PMC5596081</ArticleId><ArticleId IdType="pubmed">28943839</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Lorenzini I., Chou C.-C., Torvund M., Rogers R.S., Starr A., Zaepfel B.L., Levy J., Johannesmeyer J., Schwartz J.C., et al. Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS. Cell Rep. 2017;21:110&#x2013;125. doi: 10.1016/j.celrep.2017.09.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.09.028</ArticleId><ArticleId IdType="pmc">PMC5679478</ArticleId><ArticleId IdType="pubmed">28978466</ArticleId></ArticleIdList></Reference><Reference><Citation>Battle D., Kasim M., Yong J., Lotti F., Lau C.-K., Mouaikel J., Zhang Z., Han K., Wan L., Dreyfuss G. The SMN Complex: An Assembly Machine for RNPs. Cold Spring Harb. Symp. Quant. Boil. 2006;71:313&#x2013;320. doi: 10.1101/sqb.2006.71.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2006.71.001</ArticleId><ArticleId IdType="pubmed">17381311</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubitz A. The SMN complex. Exp. Cell Res. 2004;296:51&#x2013;56. doi: 10.1016/j.yexcr.2004.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2004.03.022</ArticleId><ArticleId IdType="pubmed">15120993</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Guarnaccia M., Spampinato A.G., La Cognata V., D&#x2019;Agata V., Cavallaro S. Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach. Mol. Neurobiol. 2018;55:1299&#x2013;1322. doi: 10.1007/s12035-017-0393-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0393-x</ArticleId><ArticleId IdType="pmc">PMC5820374</ArticleId><ArticleId IdType="pubmed">28120152</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou T., Ilangovan R., Yu F., Xu Z., Zhou J. SMN Protects cells against mutant SOD1 toxicity by increasing chaperone activity. Biochem. Biophys. Res. Commun. 2007;364:850&#x2013;855. doi: 10.1016/j.bbrc.2007.10.096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2007.10.096</ArticleId><ArticleId IdType="pmc">PMC2169267</ArticleId><ArticleId IdType="pubmed">17964281</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Muela N., Litterman N.K., Norabuena E.M., Mull J.L., Galazo M.J., Sun C., Ng S.-Y., Makhortova N.R., White A., Lynes M.M., et al. Single-Cell Analysis of SMN Reveals Its Broader Role in Neuromuscular Disease. Cell Rep. 2017;18:1484&#x2013;1498. doi: 10.1016/j.celrep.2017.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.01.035</ArticleId><ArticleId IdType="pmc">PMC5463539</ArticleId><ArticleId IdType="pubmed">28178525</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefer K., Sperling J., Sperling R. The Supraspliceosome&#x2014;A Multi-Task Machine for Regulated Pre-mRNA Processing in the Cell Nucleus. Comput. Struct. Biotechnol. J. 2014;11:113&#x2013;122. doi: 10.1016/j.csbj.2014.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2014.09.008</ArticleId><ArticleId IdType="pmc">PMC4232567</ArticleId><ArticleId IdType="pubmed">25408845</ArticleId></ArticleIdList></Reference><Reference><Citation>Azubel M., Habib N., Sperling R., Sperling J. Native Spliceosomes Assemble with Pre-mRNA to Form Supraspliceosomes. J. Mol. Boil. 2006;356:955&#x2013;966. doi: 10.1016/j.jmb.2005.11.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.11.078</ArticleId><ArticleId IdType="pubmed">16386271</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J. Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2015;12:340&#x2013;351. doi: 10.1007/s13311-015-0340-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0340-3</ArticleId><ArticleId IdType="pmc">PMC4404431</ArticleId><ArticleId IdType="pubmed">25689976</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Kim P.M., Sprecher E., Trifonov V., Gerstein M. The Importance of Bottlenecks in Protein Networks: Correlation with Gene Essentiality and Expression Dynamics. PLoS Comput. Boil. 2007;3:e59. doi: 10.1371/journal.pcbi.0030059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.0030059</ArticleId><ArticleId IdType="pmc">PMC1853125</ArticleId><ArticleId IdType="pubmed">17447836</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W., Diekstra F.P., Harschnitz O., Westeneng H.-J., Van Eijk K.R., Saris C.G.J., Groen E.J.N., Van Es M.A., Blauw H.M., Van Vught P.W.J., et al. Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. PLoS ONE. 2018;13:e0198874. doi: 10.1371/journal.pone.0198874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198874</ArticleId><ArticleId IdType="pmc">PMC6016933</ArticleId><ArticleId IdType="pubmed">29939990</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarino A.M., Di Mauro G., Ruggiero G., Geyer N., Delicato A., Foulkes N.S., Vallone D., Calabr&#xf2; V. YB-1 recruitment to stress granules in zebrafish cells reveals a differential adaptive response to stress. Sci. Rep. 2019;9:9059. doi: 10.1038/s41598-019-45468-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-45468-6</ArticleId><ArticleId IdType="pmc">PMC6588705</ArticleId><ArticleId IdType="pubmed">31227764</ArticleId></ArticleIdList></Reference><Reference><Citation>Berchtold D., Battich N., Pelkmans L. A Systems-Level Study Reveals Regulators of Membrane-less Organelles in Human Cells. Mol. Cell. 2018;72:1035&#x2013;1049.e5. doi: 10.1016/j.molcel.2018.10.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.10.036</ArticleId><ArticleId IdType="pubmed">30503769</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrakhi S., Kretov D.A., Desforges B., Dobra I., Bouhss A., Pastr&#xe9; D., Hamon L. Nanoscale Analysis Reveals the Maturation of Neurodegeneration-Associated Protein Aggregates: Grown in mRNA Granules then Released by Stress Granule Proteins. ACS Nano. 2017;11:7189&#x2013;7200. doi: 10.1021/acsnano.7b03071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.7b03071</ArticleId><ArticleId IdType="pubmed">28657719</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Spampinato A.G., Conforti F.L., D&#x2019;Agata V., Cavallaro S. Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis through a Meta-Analysis Approach. J. Mol. Neurosci. 2017;61:563&#x2013;580. doi: 10.1007/s12031-017-0898-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-017-0898-9</ArticleId><ArticleId IdType="pmc">PMC5359376</ArticleId><ArticleId IdType="pubmed">28236105</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Cavallaro S. Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: Implications for personalized therapy. Future Med. Chem. 2015;7:1335&#x2013;1359. doi: 10.4155/fmc.15.60.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc.15.60</ArticleId><ArticleId IdType="pubmed">26144267</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Conforti F.L., Parenti R., D&#x2019;Agata V., Cavallaro S. Selection of Potential Pharmacological Targets in ALS Based on Whole-Genome Expression Profiling. Curr. Med. Chem. 2015;22:2004&#x2013;2021. doi: 10.2174/0929867322666150408112135.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867322666150408112135</ArticleId><ArticleId IdType="pubmed">25850769</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin W., Rogge M. TargetingRNA: A Transformative Therapeutic Strategy. Clin. Transl. Sci. 2019;12:98&#x2013;112. doi: 10.1111/cts.12624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12624</ArticleId><ArticleId IdType="pmc">PMC6440575</ArticleId><ArticleId IdType="pubmed">30706991</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussbacher J.K., Tabet R., Yeo G.W., Lagier-Tourenne C. Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions. Neuron. 2019;102:294&#x2013;320. doi: 10.1016/j.neuron.2019.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.03.014</ArticleId><ArticleId IdType="pmc">PMC6545120</ArticleId><ArticleId IdType="pubmed">30998900</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>